Structure-activity relationships amongst 4-position quinoline methanol antimalarials that inhibit the growth of drug sensitive and resistant strains of Plasmodium falciparum
- PMID: 20097070
- DOI: 10.1016/j.bmcl.2010.01.001
Structure-activity relationships amongst 4-position quinoline methanol antimalarials that inhibit the growth of drug sensitive and resistant strains of Plasmodium falciparum
Abstract
Utilizing mefloquine as a scaffold, a next generation quinoline methanol (NGQM) library was constructed to identify early lead compounds that possess biological properties consistent with the target product profile for malaria chemoprophylaxis while reducing permeability across the blood-brain barrier. The library of 200 analogs resulted in compounds that inhibit the growth of drug sensitive and resistant strains of Plasmodium falciparum. Herein we report selected chemotypes and the emerging structure-activity relationship for this library of quinoline methanols.
Published by Elsevier Ltd.
Similar articles
-
Structure-activity relationships of 4-position diamine quinoline methanols as intermittent preventative treatment (IPT) against Plasmodium falciparum.J Med Chem. 2011 Sep 22;54(18):6277-85. doi: 10.1021/jm200647u. Epub 2011 Aug 22. J Med Chem. 2011. PMID: 21854078
-
2-Oxotetrahydroquinoline-based antimalarials with high potency and metabolic stability.J Med Chem. 2008 Feb 14;51(3):384-7. doi: 10.1021/jm7013138. Epub 2008 Jan 17. J Med Chem. 2008. PMID: 18198825
-
New 4-aminoquinoline Mannich base antimalarials. 1. Effect of an alkyl substituent in the 5'-position of the 4'-hydroxyanilino side chain.J Med Chem. 1999 Jul 29;42(15):2747-51. doi: 10.1021/jm9901374. J Med Chem. 1999. PMID: 10425085
-
Quinoline-resistance reversing agents for the malaria parasite Plasmodium falciparum.Drug Resist Updat. 2006 Aug-Oct;9(4-5):211-26. doi: 10.1016/j.drup.2006.09.002. Epub 2006 Oct 24. Drug Resist Updat. 2006. PMID: 17064951 Review.
-
Quinoline hybrids and their antiplasmodial and antimalarial activities.Eur J Med Chem. 2017 Oct 20;139:22-47. doi: 10.1016/j.ejmech.2017.07.061. Epub 2017 Jul 27. Eur J Med Chem. 2017. PMID: 28800458 Review.
Cited by
-
Imidazolopiperazines: hit to lead optimization of new antimalarial agents.J Med Chem. 2011 Jul 28;54(14):5116-30. doi: 10.1021/jm2003359. Epub 2011 Jun 23. J Med Chem. 2011. PMID: 21644570 Free PMC article.
-
Characterization of in vivo metabolites of WR319691, a novel compound with activity against Plasmodium falciparum.Eur J Drug Metab Pharmacokinet. 2011 Sep;36(3):151-8. doi: 10.1007/s13318-011-0047-8. Epub 2011 Jul 13. Eur J Drug Metab Pharmacokinet. 2011. PMID: 21751074
-
The use of a prodrug approach to minimize potential CNS exposure of next generation quinoline methanols while maintaining efficacy in in vivo animal models.Eur J Drug Metab Pharmacokinet. 2014 Dec;39(4):231-6. doi: 10.1007/s13318-013-0162-9. Epub 2014 Apr 7. Eur J Drug Metab Pharmacokinet. 2014. PMID: 24705994
-
Mefloquine targets the Plasmodium falciparum 80S ribosome to inhibit protein synthesis.Nat Microbiol. 2017 Mar 13;2:17031. doi: 10.1038/nmicrobiol.2017.31. Nat Microbiol. 2017. PMID: 28288098 Free PMC article.
-
Recent advances in malaria drug discovery.Bioorg Med Chem Lett. 2013 May 15;23(10):2829-43. doi: 10.1016/j.bmcl.2013.03.067. Epub 2013 Mar 27. Bioorg Med Chem Lett. 2013. PMID: 23587422 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources